The Commonwealth Serum Laboratories was established in Australia in 1916.
At CSL, Corporate Responsibility is about conducting our business ethically.
We offer the broadest range of quality plasma-derived and recombinant therapies in the industry.
Seqirus opened in 2015 and is the second largest influenza company in the world.
Innovation has been in the DNA of CSL since our beginning in 1916
Our product portfolio focuses on innovation in new products
Help us deliver on our promise to save lives and protect the health of people.
Diversity and inclusion are top priorities for CSL.
View our ASX announcements
Visit this page to see all of our current news releases
CSL Behring AG Publishes Offer Prospectus On Public Tender Offer For All Publicly Held Shares Of Vifor Pharma Ltd.
Statement attributable to Greg Boss, Executive Vice President - Legal, and CSL Limited Group General Counsel.
CSL ranked fourth on the Health Industry list, from a total of more than 750 organisations nominated in all sectors across Au…
CSL Plasma U.S. collection centers are preparing to undergo implementation of newly cleared Rika Plasma Donation System, with…
With 25,000 global employees, CSL is one of 500 Large Employers recognized across 25 industry sectors
Popular search terms:
Americas
Asia Pacific
Europe
